← Eichor
Study identifier: NCT02469662 Synced from ClinicalTrials.gov · July 28, 2026
● Recruiting

Clinical Outcomes Study of the Nexel Total Elbow

Condition: Elbow Joint Destruction · Post-traumatic Lesions · Ankylosed Joints  ·  Sponsor: Zimmer Biomet

PhaseNA
Planned participants134
Who can joinAll sexes, 18 Years to no upper limit
Healthy volunteersNo

About this study

The objectives of the study are to confirm safety and performance of the Zimmer Nexel Total Elbow when used in primary or revision total elbow replacement.

This description comes directly from the study's public registry record.

Talk to the study team

Richard Marek  ·  574-453-7567  ·  richard.marek@zimmerbiomet.com

Ryan Boylan  ·  574-527-7934  ·  ryan.boylan@zimmerbiomet.com

Always discuss trial participation with your own doctor first.

Locations (11)

Panorama Orthopedics and Spine CenterGolden, Colorado, United StatesRecruiting
OrthoCarolina Research InstituteCharlotte, North Carolina, United StatesRecruiting
Rothman InstitutePhiladelphia, Pennsylvania, United StatesRecruiting
Campbell ClinicGermantown, Tennessee, United StatesRecruiting
Sydney Shoulder & Elbow, NSWSydney, New South Wales, AustraliaTerminated
Coxa HospitalTampere, FinlandRecruiting
Hôpital Purpan (Centre Hospitalier Universitaire Toulouse)Toulouse, FranceTerminated
Arcus SportklinikPforzheim, GermanyTerminated
AO MaurizianoTorino, ItalyRecruiting
Amphia Ziekenhuis BredaBreda, NetherlandsActive Not Recruiting
WrightingtonWigan, United KingdomRecruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT02469662